Industry litigation – Page 15
-
Business
FDA takes action to remove biosimilars roadblock
The US Food and Drug Administration proposes system to name biosimilar drugs
-
BusinessFemale sexual desire drug approved
Concerns raised over efficacy, side effects and use of advocacy campaigning to influence regulatory decisions
-
BusinessIndian pharma under increased regulatory scrutiny
Import bans and tightened rules pose a significant challenge for companies
-
BusinessPorous pills could be largest industrial 3D printing use
US grants first-of-a-kind approval for Aprecia’s epilepsy tablets exploiting porous structure
-
BusinessGreek crisis puts pressure on pharmaceuticals
Public spending cuts and capital restrictions on banks have exacerbated drug supply problems in Greece
-
BusinessDeadly chemical blast at Chinese port
Explosion at warehouse in Tianjin kills at least 50 and injures hundreds, while ammonia leak sparks mass evacuations in Nanchong
-
BusinessUS regulator says DuPont’s safety programme ‘failed’
The US Occupational Safety and Health Administration has again proposed to fine DuPont after uncovering ‘repeated’ and ‘serious’ lapses in the company’s worker safety programme
-
Business
US import ban imposed on Indian pharma firm
Concerns over manufacturing processes at Emcure facility prompts Food and Drug Administration to block drug shipments
-
Business
Blast kills six at South Korean chemical plant
One further worker injured as tank explodes during welding work
-
Business
Alnylam accuses Dicerna of stealing trade secrets
Firm claims rights to GalNAc conjugated siRNA technology acquired from Merck & Co
-
Business
Suspect suicide won’t end trade secret theft probe
An ex-PPG chemist who was arrested for selling trade secrets to a Chinese firm has killed himself, but the Justice Department will continue its investigation
-
BusinessBMS sues executive for joining rival company
Bristol-Myers Squibb’s lawsuit against its former immuno-oncology chief who left to work for AstraZeneca has implications for biopharma industry
-
Business
Teva fined $1.2bn in pay-for-delay case
Company illegally blocked generic competition of sleep disorder drug, and settlement terms tighten up rules on anticompetitive behaviour
-
Business
Achillion partners with Janssen to boost hepatitis C pipeline
Development deal worth up to $1.1bn includes three investigational drugs aiming to extend treatment options in fast-moving market
-
Business
Actavis plan to thwart generics blocked
Company prevented from withdrawing original formulation of Alzheimer’s drug to force patients onto extended release version and extend patent exclusivity
-
Business
DuPont fined over fatal leak
Company lacked proper safety procedures to prevent deaths of four workers in methyl mercaptan leak
-
Business
Canada sets climate target
Canada aims to cut greenhouse gas emissions from energy-intensive sectors by 30% from 2005 levels by 2030
-
Business
GSK commits to HIV research
Firm will partner with US university and cancels plan to sell its share of ViiV Healthcare joint venture
-
Business
Judge refuses Freedom Industries’ bankruptcy plan
Court says $6.7m proposal from the company responsible for huge West Virginia chemical spill is inadequate
-
Business
DuPont overcomes investor challenge
Shareholders decline to elect activist board nominees in a show of support for the current management’s strategy